Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
rebif 44 solution injectable en seringue pré-remplie
merck (schweiz) ag - interferonum bêta-1a adnr - solution injectable en seringue pré-remplie - interferonum beta-1a adnr 44 µg corresp. 12 mio u.i., alcohol benzylicus 2.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.04 mg. - multiple sklerose - biotechnologika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
rebif 22 multidose solution injectable en cartouche
merck (schweiz) ag - interferonum bêta-1a adnr - solution injectable en cartouche - interferonum beta-1a adnr 66 µg corresp. 18 mio u.i., alcohol benzylicus 7.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, acidum aceticum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 1.5 ml corresp. natrium max. 0.04 mg. - multiple sklerose - biotechnologika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
rebif 44 multidose solution injectable en cartouche
merck (schweiz) ag - interferonum bêta-1a adnr - solution injectable en cartouche - interferonum beta-1a adnr 132 µg corresp. 36 mio u.i., alcohol benzylicus 7.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, acidum aceticum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 1.5 ml corresp. natrium max. 0.06 mg. - multiple sklerose - biotechnologika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
rebif 22 rebidose solution injectable en stylo prérempli
merck (schweiz) ag - interferonum bêta-1a adnr - solution injectable en stylo prérempli - interferonum beta-1a adnr 22 µg corresp. 6 mio u.i., alcohol benzylicus 2.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.03 mg. - multiple sklerose - biotechnologika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
rebif 44 rebidose solution injectable en stylo prérempli
merck (schweiz) ag - interferonum bêta-1a adnr - solution injectable en stylo prérempli - interferonum beta-1a adnr 44 µg corresp. 12 mio u.i., alcohol benzylicus 2.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.04 mg. - multiple sklerose - biotechnologika
Canada -
français -
Health Canada
rebif trousse
emd serono, a division of emd inc., canada - interféron bêta-1a; interféron bêta-1a - trousse - 8.8mcg; 22mcg - interféron bêta-1a 8.8mcg; interféron bêta-1a 22mcg - immunomodulatory agents
Canada -
français -
Health Canada
plegridy liquide
biogen canada inc - peginterfÉron bÊta-1a - liquide - 63mcg - peginterfÉron bÊta-1a 63mcg - interferons
Canada -
français -
Health Canada
plegridy liquide
biogen canada inc - peginterfÉron bÊta-1a - liquide - 94mcg - peginterfÉron bÊta-1a 94mcg - interferons
Canada -
français -
Health Canada
plegridy liquide
biogen canada inc - peginterfÉron bÊta-1a - liquide - 125mcg - peginterfÉron bÊta-1a 125mcg - interferons
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
avonex lyophilisat
biogen switzerland ag - interferonum beta-1a adnr - lyophilisat - praeparatio cryodesiccata: interferonum beta-1a adnr 33 µg, albuminum humanum, dinatrii phosphas monohydricus, natrii dihydrogenophosphas, natrii chloridum, pro vitro. solvens: aqua ad iniectabilia 1.1 ml. solutio reconstituta: corresp. interferonum beta-1a adnr 30 µg/ml. - multiple sklerose - biotechnologika